Contract Notice Detail

Summary Information

Summary Information
244,241.152106 Euro
 
45021724 
Aquisição de Medicamentos para o sistema nervoso central II, ao abrigo do CPA 2023/436 
Tendering Phase
Awarded
Aquisição de Medicamentos para o sistema nervoso central II, ao abrigo do CPA 2023/436 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
S168 - SUMATRIPTANO C/ APLICADOR [6MG/0,5ML; SER]-8 (Months)
P1275 - PERAMPANEL [2 MG; CÁP/ COMP]-8 (Months)
B390 - BETA-HISTINA [24 MG; CÁP/COMP]-8 (Months)
A5336 - APOMORFINA [5MG/ ML; 10 ML; SERINGA]-8 (Months)
B121 - BIPERIDENO [5 MG/1 ML; F/AMP]-8 (Months)
B120 - BIPERIDENO [2 MG; CÁP/COMP]-8 (Months)
A630 - AMANTADINA [100 MG; CÁP/COMP]-8 (Months)
A709 - ACIDO VALPRÓICO (LP/ LM) [500 MG; CÁP/COMP]-8 (Months)
B71 - BETA-HISTINA [16 MG; CÁP/COMP]-8 (Months)
B189 - BUSPIRONA [10 MG; CÁP/COMP]-8 (Months)
C38 - CARBAMAZEPINA [20 MG/ML; SUSP ORAL; FRS]-8 (Months)
C40 - CARBAMAZEPINA [200 MG; CÁP/COMP]-8 (Months)
D318 - DONEPEZILO [5 MG; CÁP/COMP]-8 (Months)
F523 - FOSAPREPITANT [150 MG; F/AMP]-8 (Months)
G178 - GABAPENTINA [100 MG; CÁP/COMP]-8 (Months)
G179 - GABAPENTINA [300 MG; CÁP/COMP]-8 (Months)
G180 - GABAPENTINA [400 MG; CÁP/COMP]-8 (Months)
L31 - LAMOTRIGINA [100 MG; CÁP/COMP]-8 (Months)
L32 - LAMOTRIGINA [25MG; CÁP/COMP]-8 (Months)
L566 - LEVETIRACETAM [100 MG/ML; SOL ORAL; FRS]-8 (Months)
L67 - LEVODOPA + CARBIDOPA [250 + 25 MG; CÁP/COMP]-8 (Months)
M159 - MIDAZOLAM [50 MG/10 ML; F/AMP]-8 (Months)
M160 - MIDAZOLAM [15 MG/3 ML; F/AMP]-8 (Months)
N133 - NICOTINA [14 MG/ 24 H; SIST TRANSD]-8 (Months)
N136 - NICOTINA [2 MG; COMP CHUPAR/ PASTILHA/ GOMA P/A MASCAR]-8 (Months)
N137 - NICOTINA [21 MG/ 24 H; SIST TRANSD]-8 (Months)
N140 - NICOTINA [7 MG/24 H; SIST TRANSD]-8 (Months)
O19 - ONDANSETROM [8 MG; CÁP/COMP]-8 (Months)
P1276 - PERAMPANEL [4 MG; CÁP/ COMP]-8 (Months)
P1278 - PERAMPANEL [8 MG; CÁP/ COMP]-8 (Months)
P1612 - PERAMPANEL [0.5 MG/ML; SUSP ORAL; FRS]-8 (Months)
R47 - RILUZOL [50 MG; CÁP/COMP]-8 (Months)
R914 - RIVASTIGMINA [3 MG; CÁP/COMP]-8 (Months)
R976 - RUFINAMIDA [200 MG; CÁP/COMP]-8 (Months)
Z12 - ZOLPIDEM [10 MG; CÁP/COMP]-8 (Months)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Alameda Prof Hernâni Monteiro Paranhos Porto Área Metropolitana do Porto PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
5/10/2024 3:31 PM (UTC +1 hour)
 
4/10/2023 3:01 PM (UTC +1 hour)
 
5/16/2024 5:00 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
Convite_AQ_CPA2023436_ULSSJ.pdfConvite_AQ_CPA2023436_ULSSJ.pdfDownload
Anexo_I_Mapa_QT_QA_CPA 2023436.xlsxAnexo_I_Mapa_QT_QA_CPA 2023436.xlsxDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
1
Lot Title
A5336 - APOMORFINA [5MG/ ML; 10 ML; SERINGA]
Base Price
51.566,320000

1.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
A5336 APOMORFINA [5MG/ ML; 10 ML; SERINGA] 2.770,000000 UN
Buyer Comment: 504591126 | Italfarmaco, Produtos Farmacêuticos, Lda. | CPA:2023436/70/0216 | NºAIM:5411616;
TOTAL (The amounts shown do not include VAT)
2
Lot Title
B121 - BIPERIDENO [5 MG/1 ML; F/AMP]
Base Price
194,910000

2.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
B121 BIPERIDENO [5 MG/1 ML; F/AMP] 438,000000 UN
Buyer Comment: 503934640 | Alloga Logifarma, S.A. | CPA:2023436/354/0353 | NºAIM:8232207;
TOTAL (The amounts shown do not include VAT)
3
Lot Title
B120 - BIPERIDENO [2 MG; CÁP/COMP]
Base Price
330,330000

3.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
B120 BIPERIDENO [2 MG; CÁP/COMP] 7.150,000000 UN
Buyer Comment: 503934640 | Alloga Logifarma, S.A. | CPA:2023436/354/0352 | NºAIM:8920710;
TOTAL (The amounts shown do not include VAT)
4
Lot Title
A630 - AMANTADINA [100 MG; CÁP/COMP]
Base Price
82,350000

4.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
A630 AMANTADINA [100 MG; CÁP/COMP] 540,000000 UN
Buyer Comment: 505792362 | Overpharma, Produtos Médicos e Farmacêuticos, Lda. | CPA:2023436/247/0197 | NºAIM:9368027;
TOTAL (The amounts shown do not include VAT)
5
Lot Title
A709 - ACIDO VALPRÓICO (LP/ LM) [500 MG; CÁP/COMP]
Base Price
1.181,280000

5.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
A709 ACIDO VALPRÓICO (LP/ LM) [500 MG; CÁP/COMP] 11.040,000000 UN
Buyer Comment: 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0109 | NºAIM:5226881;
TOTAL (The amounts shown do not include VAT)
6
Lot Title
B71 - BETA-HISTINA [16 MG; CÁP/COMP]
Base Price
237,000000

6.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
B71 BETA-HISTINA [16 MG; CÁP/COMP] 4.740,000000 UN
Buyer Comment: 500384045 | Laboratório Medinfar - Produtos Farmacêuticos, S.A. | CPA:2023436/93/0340 | NºAIM:5106596;
TOTAL (The amounts shown do not include VAT)
7
Lot Title
B189 - BUSPIRONA [10 MG; CÁP/COMP]
Base Price
303,600000

7.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
B189 BUSPIRONA [10 MG; CÁP/COMP] 2.760,000000 UN
Buyer Comment: 503894427 | D.L.A. Farmaceutica, S.A. | CPA:2023436/542/0368 | NºAIM:9767830; 505792362 | Overpharma, Produtos Médicos e Farmacêuticos, Lda. | CPA:2023436/247/0207 | NºAIM:9666032; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0143 | NºAIM:8776732; 508907365 | Orionfin Unipessoal, Lda. | CPA:2023436/746/0015 | NºAIM:5839006;
TOTAL (The amounts shown do not include VAT)
8
Lot Title
C38 - CARBAMAZEPINA [20 MG/ML; SUSP ORAL; FRS]
Base Price
73,920000

8.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
C38 CARBAMAZEPINA [20 MG/ML; SUSP ORAL; FRS] 32,000000 UN
Buyer Comment: 500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023436/128/0022 | NºAIM:4979191;
TOTAL (The amounts shown do not include VAT)
9
Lot Title
C40 - CARBAMAZEPINA [200 MG; CÁP/COMP]
Base Price
135,000000

9.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
C40 CARBAMAZEPINA [200 MG; CÁP/COMP] 3.000,000000 UN
Buyer Comment: 500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023436/128/0021 | NºAIM:9144030; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0165 | NºAIM:3202983;
TOTAL (The amounts shown do not include VAT)
10
Lot Title
D318 - DONEPEZILO [5 MG; CÁP/COMP]
Base Price
319,200000

10.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
D318 DONEPEZILO [5 MG; CÁP/COMP] 6.384,000000 UN
Buyer Comment: 506985261 | Sandoz Farmacêutica, Lda. | CPA:2023436/326/0384 | NºAIM:5149612; 507981227 | Krka Farmacêutica, Lda. | CPA:2023436/901/0035 | NºAIM:5184270; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0167 | NºAIM:5687421;
TOTAL (The amounts shown do not include VAT)
11
Lot Title
F523 - FOSAPREPITANT [150 MG; F/AMP]
Base Price
40.068,000000

11.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
F523 FOSAPREPITANT [150 MG; F/AMP] 1.060,000000 UN
Buyer Comment: 500191360 | Merck Sharp & Dohme, Lda. | CPA:2023436/193/0263 | NºAIM:5324454; 502266791 | Hikma Farmacêutica, S.A. | CPA:2023436/62/0267 | NºAIM:5772876;
TOTAL (The amounts shown do not include VAT)
12
Lot Title
G178 - GABAPENTINA [100 MG; CÁP/COMP]
Base Price
3.203,820000

12.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
G178 GABAPENTINA [100 MG; CÁP/COMP] 62.820,000000 UN
Buyer Comment: 502248793 | Mylan, Lda. | CPA:2023436/120/0421 | NºAIM:5815584; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0120 | NºAIM:5373600;
TOTAL (The amounts shown do not include VAT)
13
Lot Title
G179 - GABAPENTINA [300 MG; CÁP/COMP]
Base Price
2.035,140000

13.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
G179 GABAPENTINA [300 MG; CÁP/COMP] 19.020,000000 UN
Buyer Comment: 500162220 | Faes Farma Portugal, S.A. | CPA:2023436/104/0282 | NºAIM:5200548; 501505334 | Farmoz - Soc. Técnico Medicinal, S.A. | CPA:2023436/46/0058 | NºAIM:3847498; 502248793 | Mylan, Lda. | CPA:2023436/120/0422 | NºAIM:5815683; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0121 | NºAIM:5373626;
TOTAL (The amounts shown do not include VAT)
14
Lot Title
G180 - GABAPENTINA [400 MG; CÁP/COMP]
Base Price
525,600000

14.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
G180 GABAPENTINA [400 MG; CÁP/COMP] 4.380,000000 UN
Buyer Comment: 500162220 | Faes Farma Portugal, S.A. | CPA:2023436/104/0283 | NºAIM:5200555; 501505334 | Farmoz - Soc. Técnico Medicinal, S.A. | CPA:2023436/46/0059 | NºAIM:3847597; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0122 | NºAIM:5373642;
TOTAL (The amounts shown do not include VAT)
15
Lot Title
L31 - LAMOTRIGINA [100 MG; CÁP/COMP]
Base Price
269,360000

15.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
L31 LAMOTRIGINA [100 MG; CÁP/COMP] 2.072,000000 UN
Buyer Comment: 500139962 | GlaxoSmithKline - Produtos Farmacêuticos, Lda. | CPA:2023436/68/0330 | NºAIM:5792742; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0130 | NºAIM:5337605;
TOTAL (The amounts shown do not include VAT)
16
Lot Title
L32 - LAMOTRIGINA [25MG; CÁP/COMP]
Base Price
65,800000

16.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
L32 LAMOTRIGINA [25MG; CÁP/COMP] 1.400,000000 UN
Buyer Comment: 500139962 | GlaxoSmithKline - Produtos Farmacêuticos, Lda. | CPA:2023436/68/0331 | NºAIM:5792700; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0131 | NºAIM:5337563;
TOTAL (The amounts shown do not include VAT)
17
Lot Title
L566 - LEVETIRACETAM [100 MG/ML; SOL ORAL; FRS]
Base Price
3.678,400000

17.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
L566 LEVETIRACETAM [100 MG/ML; SOL ORAL; FRS] 418,000000 UN
Buyer Comment: 500162220 | Faes Farma Portugal, S.A. | CPA:2023436/104/0287 | NºAIM:5383278; 500492867 | Jaba Recordati, S.A. | CPA:2023436/72/0360 | NºAIM:5383211; 501505334 | Farmoz - Soc. Técnico Medicinal, S.A. | CPA:2023436/46/0062 | NºAIM:5383658; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0441 | NºAIM:5713771;
TOTAL (The amounts shown do not include VAT)
18
Lot Title
L67 - LEVODOPA + CARBIDOPA [250 + 25 MG; CÁP/COMP]
Base Price
147,368340

18.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
L67 LEVODOPA + CARBIDOPA [250 + 25 MG; CÁP/COMP] 1.260,000000 UN
Buyer Comment: 503640719 | Organon Portugal, Sociedade Unipessoal, Lda. | CPA:2023436/2193/0432 | NºAIM:8372557;
TOTAL (The amounts shown do not include VAT)
19
Lot Title
M159 - MIDAZOLAM [50 MG/10 ML; F/AMP]
Base Price
11.750,400000

19.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
M159 MIDAZOLAM [50 MG/10 ML; F/AMP] 21.760,000000 UN
Buyer Comment: 501169580 | Labesfal - Laboratórios Almiro, S.A. | CPA:2023436/107/0303 | NºAIM:5506191; 502266791 | Hikma Farmacêutica, S.A. | CPA:2023436/62/0272 | NºAIM:5592118; 505792362 | Overpharma, Produtos Médicos e Farmacêuticos, Lda. | CPA:2023436/247/0198 | NºAIM:5820303; 508622263 | Accord Healthcare, Unipessoal, Lda. | CPA:2023436/528/0081 | NºAIM:5468806;
TOTAL (The amounts shown do not include VAT)
20
Lot Title
M160 - MIDAZOLAM [15 MG/3 ML; F/AMP]
Base Price
3.100,500000

20.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
M160 MIDAZOLAM [15 MG/3 ML; F/AMP] 11.700,000000 UN
Buyer Comment: 501169580 | Labesfal - Laboratórios Almiro, S.A. | CPA:2023436/107/0304 | NºAIM:5505896; 502266791 | Hikma Farmacêutica, S.A. | CPA:2023436/62/0271 | NºAIM:5472840; 505792362 | Overpharma, Produtos Médicos e Farmacêuticos, Lda. | CPA:2023436/247/0199 | NºAIM:5788955; 508622263 | Accord Healthcare, Unipessoal, Lda. | CPA:2023436/528/0082 | NºAIM:5206578;
TOTAL (The amounts shown do not include VAT)
21
Lot Title
N133 - NICOTINA [14 MG/ 24 H; SIST TRANSD]
Base Price
10.705,668750

21.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
N133 NICOTINA [14 MG/ 24 H; SIST TRANSD] 6.650,000000 UN
Buyer Comment: 500276994 | Haleon Portugal, Lda. | CPA:2023436/218/0002 | NºAIM:5943386; 506112233 | Perrigo Portugal, Lda. | CPA:2023436/226/0395 | NºAIM:4944385;
TOTAL (The amounts shown do not include VAT)
22
Lot Title
N136 - NICOTINA [2 MG; COMP CHUPAR/ PASTILHA/ GOMA P/A MASCAR]
Base Price
468,756000

22.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
N136 NICOTINA [2 MG; COMP CHUPAR/ PASTILHA/ GOMA P/A MASCAR] 2.400,000000 UN
Buyer Comment: 500276994 | Haleon Portugal, Lda. | CPA:2023436/218/0003 | NºAIM:5150487; 506112233 | Perrigo Portugal, Lda. | CPA:2023436/226/0399 | NºAIM:5648175;
TOTAL (The amounts shown do not include VAT)
23
Lot Title
N137 - NICOTINA [21 MG/ 24 H; SIST TRANSD]
Base Price
16.936,156160

23.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
N137 NICOTINA [21 MG/ 24 H; SIST TRANSD] 10.472,000000 UN
Buyer Comment: 500276994 | Haleon Portugal, Lda. | CPA:2023436/218/0004 | NºAIM:5943782; 506112233 | Perrigo Portugal, Lda. | CPA:2023436/226/0397 | NºAIM:4944880;
TOTAL (The amounts shown do not include VAT)
24
Lot Title
N140 - NICOTINA [7 MG/24 H; SIST TRANSD]
Base Price
2.154,600000

24.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
N140 NICOTINA [7 MG/24 H; SIST TRANSD] 1.596,000000 UN
Buyer Comment: 500276994 | Haleon Portugal, Lda. | CPA:2023436/218/0005 | NºAIM:5943188; 506112233 | Perrigo Portugal, Lda. | CPA:2023436/226/0396 | NºAIM:4943882;
TOTAL (The amounts shown do not include VAT)
25
Lot Title
O19 - ONDANSETROM [8 MG; CÁP/COMP]
Base Price
2.621,850000

25.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
O19 ONDANSETROM [8 MG; CÁP/COMP] 34.050,000000 UN
Buyer Comment: 501505334 | Farmoz - Soc. Técnico Medicinal, S.A. | CPA:2023436/46/0438 | NºAIM:5685193;
TOTAL (The amounts shown do not include VAT)
26
Lot Title
P1276 - PERAMPANEL [4 MG; CÁP/ COMP]
Base Price
1.548,033760

26.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
P1276 PERAMPANEL [4 MG; CÁP/ COMP] 728,000000 UN
Buyer Comment: 507847660 | EF - Eisai Farmacêutica, Unipessoal, Lda. | CPA:2023436/493/0257 | NºAIM:5468202;
TOTAL (The amounts shown do not include VAT)
27
Lot Title
P1278 - PERAMPANEL [8 MG; CÁP/ COMP]
Base Price
554,158080

27.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
P1278 PERAMPANEL [8 MG; CÁP/ COMP] 224,000000 UN
Buyer Comment: 507847660 | EF - Eisai Farmacêutica, Unipessoal, Lda. | CPA:2023436/493/0255 | NºAIM:5468228;
TOTAL (The amounts shown do not include VAT)
28
Lot Title
P1612 - PERAMPANEL [0.5 MG/ML; SUSP ORAL; FRS]
Base Price
832,050000

28.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
P1612 PERAMPANEL [0.5 MG/ML; SUSP ORAL; FRS] 15,000000 UN
Buyer Comment: 507847660 | EF - Eisai Farmacêutica, Unipessoal, Lda. | CPA:2023436/493/0259 | NºAIM:5758743;
TOTAL (The amounts shown do not include VAT)
29
Lot Title
R47 - RILUZOL [50 MG; CÁP/COMP]
Base Price
87.050,880000

29.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
R47 RILUZOL [50 MG; CÁP/COMP] 42.672,000000 UN
Buyer Comment: 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0134 | NºAIM:5213814;
TOTAL (The amounts shown do not include VAT)
30
Lot Title
R914 - RIVASTIGMINA [3 MG; CÁP/COMP]
Base Price
495,936000

30.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
R914 RIVASTIGMINA [3 MG; CÁP/COMP] 1.512,000000 UN
Buyer Comment: 500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023436/128/0028 | NºAIM:2708188; 506985261 | Sandoz Farmacêutica, Lda. | CPA:2023436/326/0391 | NºAIM:5462007;
TOTAL (The amounts shown do not include VAT)
31
Lot Title
R976 - RUFINAMIDA [200 MG; CÁP/COMP]
Base Price
227,839920

31.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
R976 RUFINAMIDA [200 MG; CÁP/COMP] 240,000000 UN
Buyer Comment: 507847660 | EF - Eisai Farmacêutica, Unipessoal, Lda. | CPA:2023436/493/0260 | NºAIM:5026430;
TOTAL (The amounts shown do not include VAT)
32
Lot Title
Z12 - ZOLPIDEM [10 MG; CÁP/COMP]
Base Price
505,705200

32.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
Z12 ZOLPIDEM [10 MG; CÁP/COMP] 12.012,000000 UN
Buyer Comment: 506985261 | Sandoz Farmacêutica, Lda. | CPA:2023436/326/0394 | NºAIM:5068788; 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0156 | NºAIM:5647904;
TOTAL (The amounts shown do not include VAT)
33
Lot Title
S168 - SUMATRIPTANO C/ APLICADOR [6MG/0,5ML; SER]
Base Price
323,000000

33.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
S168 SUMATRIPTANO C/ APLICADOR [6MG/0,5ML; SER] 34,000000 UN
Buyer Comment: 500139962 | GlaxoSmithKline - Produtos Farmacêuticos, Lda. | CPA:2023436/68/0338 | NºAIM:8788604;
TOTAL (The amounts shown do not include VAT)
34
Lot Title
P1275 - PERAMPANEL [2 MG; CÁP/ COMP]
Base Price
189,539896

34.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
P1275 PERAMPANEL [2 MG; CÁP/ COMP] 182,000000 UN
Buyer Comment: 507847660 | EF - Eisai Farmacêutica, Unipessoal, Lda. | CPA:2023436/493/0258 | NºAIM:5468160;
TOTAL (The amounts shown do not include VAT)
35
Lot Title
B390 - BETA-HISTINA [24 MG; CÁP/COMP]
Base Price
358,680000

35.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
B390 BETA-HISTINA [24 MG; CÁP/COMP] 5.880,000000 UN
Buyer Comment: 508107997 | Generis Farmacêutica, S.A. | CPA:2023436/263/0444 | NºAIM:5640248;
TOTAL (The amounts shown do not include VAT)

Evaluation

Evaluation
Vision

Avaliação

Definir modelo de avaliação
Modalidade de avaliação
Método de Avaliação
Divulgar critérios de avaliação

Critérios da Avaliação

1 - A5336 - APOMORFINA [5MG/ ML; 10 ML; SERINGA]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

2 - B121 - BIPERIDENO [5 MG/1 ML; F/AMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

3 - B120 - BIPERIDENO [2 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

4 - A630 - AMANTADINA [100 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

5 - A709 - ACIDO VALPRÓICO (LP/ LM) [500 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

6 - B71 - BETA-HISTINA [16 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

7 - B189 - BUSPIRONA [10 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

8 - C38 - CARBAMAZEPINA [20 MG/ML; SUSP ORAL; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

9 - C40 - CARBAMAZEPINA [200 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

10 - D318 - DONEPEZILO [5 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

11 - F523 - FOSAPREPITANT [150 MG; F/AMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

12 - G178 - GABAPENTINA [100 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

13 - G179 - GABAPENTINA [300 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

14 - G180 - GABAPENTINA [400 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

15 - L31 - LAMOTRIGINA [100 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

16 - L32 - LAMOTRIGINA [25MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

17 - L566 - LEVETIRACETAM [100 MG/ML; SOL ORAL; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

18 - L67 - LEVODOPA + CARBIDOPA [250 + 25 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

19 - M159 - MIDAZOLAM [50 MG/10 ML; F/AMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

20 - M160 - MIDAZOLAM [15 MG/3 ML; F/AMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

21 - N133 - NICOTINA [14 MG/ 24 H; SIST TRANSD]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

22 - N136 - NICOTINA [2 MG; COMP CHUPAR/ PASTILHA/ GOMA P/A MASCAR]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

23 - N137 - NICOTINA [21 MG/ 24 H; SIST TRANSD]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

24 - N140 - NICOTINA [7 MG/24 H; SIST TRANSD]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

25 - O19 - ONDANSETROM [8 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

26 - P1276 - PERAMPANEL [4 MG; CÁP/ COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

27 - P1278 - PERAMPANEL [8 MG; CÁP/ COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

28 - P1612 - PERAMPANEL [0.5 MG/ML; SUSP ORAL; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

29 - R47 - RILUZOL [50 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

30 - R914 - RIVASTIGMINA [3 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

31 - R976 - RUFINAMIDA [200 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

32 - Z12 - ZOLPIDEM [10 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

33 - S168 - SUMATRIPTANO C/ APLICADOR [6MG/0,5ML; SER]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

34 - P1275 - PERAMPANEL [2 MG; CÁP/ COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

35 - B390 - BETA-HISTINA [24 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...